Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-02-24 @ 2:30 PM
Study NCT ID:
NCT05461794
Status:
TERMINATED
Last Update Posted:
2025-06-13
First Post:
2022-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-14
First Submit QC Date:
None
Study First Post Date:
2022-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-06-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-29
Last Update Post Date:
2025-06-13
Last Update Post Date Type:
ACTUAL